Hong Kong Stock Exchange · Consumer Defensive
Invest in Giant Biogene Holding stock from India
Indian and foreign residents can buy Giant Biogene Holding (2367) shares directly through Paasa.
By Paasa · Updated
Giant Biogene Holding at a glance
- Price
- HK$24.38+HK$0.56 (2.35%)
- Market cap
- HK$25.88B
- Day range
- HK$23.74 – HK$24.50
- P/E
- 13.35
- Dividend yield
- 5.70%
- Volume
- 1.81M
- 1 month
- -9.03%
- 6 months
- -15.99%
- YTD
- -26.74%
- 1 year
- -56.73%
- 5 years
- —
Giant Biogene Holding statements, FY2021–FY2025
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | CN¥5.5B | CN¥5.5B | CN¥3.5B | CN¥2.4B | CN¥1.6B |
| Gross profit | CN¥4.4B | CN¥4.5B | CN¥2.9B | CN¥2.0B | CN¥1.4B |
| Operating income | CN¥2.1B | CN¥2.3B | CN¥1.7B | CN¥1.1B | CN¥914.6M |
| Net income | CN¥1.9B | CN¥2.1B | CN¥1.5B | CN¥1.0B | CN¥828.1M |
| Earnings per share | CN¥1.83 | CN¥2.10 | CN¥1.49 | CN¥0.99 | CN¥0.84 |
| EBITDA | CN¥2.2B | CN¥2.3B | CN¥1.8B | CN¥1.2B | CN¥933.6M |
| Total assets | CN¥10.8B | CN¥8.0B | CN¥5.0B | CN¥3.1B | CN¥7.9B |
| Total debt | CN¥9.7M | CN¥6.7M | CN¥2.7M | CN¥2.6M | CN¥7.7B |
| Cash and short-term investments | CN¥8.3B | CN¥5.9B | CN¥3.8B | CN¥2.2B | CN¥7.3B |
| Shareholders' equity | CN¥9.9B | CN¥7.1B | CN¥4.4B | CN¥2.8B | CN¥1.0B |
| Operating cash flow | CN¥1.9B | CN¥2.0B | CN¥1.6B | CN¥931.6M | CN¥692.4M |
| Free cash flow | CN¥1.5B | CN¥1.8B | CN¥1.4B | CN¥778.4M | CN¥581.2M |
| Capital expenditure | −CN¥417.0M | −CN¥246.8M | −CN¥228.4M | −CN¥153.2M | −CN¥111.2M |
Fiscal years as reported, the latest ending 31 Dec 2025. Figures in CNY; a dash means the provider reported nothing for that line.
Peer comparison
| Company | Ticker | Price | Market cap |
|---|---|---|---|
| Uni-President China | 0220.HK | HK$7.02 | HK$30.32B |
| ZJLD | 6979.HK | HK$7.89 | HK$26.74B |
| China Feihe | 6186.HK | HK$2.74 | HK$24.13B |
| Hengan International | 1044.HK | HK$19.69 | HK$22.66B |
| First Pacific | 0142.HK | HK$4.85 | HK$20.65B |
| China Resources Beverage | 2460.HK | HK$7.35 | HK$17.63B |
| China Tobacco International (HK) | 6055.HK | HK$23.60 | HK$16.32B |
| WEILONG Delicious Global | 9985.HK | HK$6.65 | HK$16.15B |
Peers as grouped by the data provider. This is not an investment recommendation.
How to invest in Giant Biogene Holding from India
Step 1
Open your Paasa account
KYC takes a few minutes: PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Step 2
Add funds from your Indian bank account
Remit up to $250,000 a year under the RBI's Liberalised Remittance Scheme. Your bank converts the rupees to US dollars at its rate on the day you remit, and Interactive Brokers converts the dollars to HKD when you buy.
Step 3
Search 2367 and buy
Find Giant Biogene Holding by name or by its ticker, 2367, and place your order. Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share.
Why invest in Giant Biogene Holding from India
What Giant Biogene Holding does
Giant Biogene Holding Co., Ltd. operates as an investment holding entity, primarily engaged in the research, development, production, and sale of beauty and wellness products based on bioactive materials throughout the People's Republic of China. The company also manufactures functional foods leveraging rare ginsenosides technology and provides medical devices. Giant Biogene Holding operates in the Household & Personal Products industry within the Consumer Defensive sector.
Paasa handles the paperwork
Investing abroad brings paperwork with it: remittance filings, capital gains reporting, foreign asset disclosure. Paasa prepares all of it for you. Your India-ready tax reports arrive at year end, ready to file.
Frequently asked questions
Can I buy Giant Biogene Holding stock from India?
Yes. Indian residents and NRIs can buy Giant Biogene Holding (2367) shares directly through Paasa. Giant Biogene Holding is listed on the Hong Kong Stock Exchange, in the Household & Personal Products industry. Your money leaves India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name at Interactive Brokers.
Do I need to buy a full Giant Biogene Holding share?
Usually more than one, and not a fraction: many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share. At HK$24.38 a share, size the order by the lot, not by the share.
How are Giant Biogene Holding dividends taxed for Indian investors?
Giant Biogene Holding trades on the Hong Kong Stock Exchange but is domiciled in China, so any withholding on its dividends follows that country's rules rather than those of Hong Kong. Dividends are taxed at your slab rate in India. Paasa's dividend report shows the gross amount and any tax withheld for each payment.
What tax do I pay in India when I sell Giant Biogene Holding shares?
Hong Kong generally does not levy capital gains tax on non-resident individual investors for HKEX-listed stocks. In India, gains on shares held for more than 24 months are long-term and taxed at 12.5%, and gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. Both are worked out in rupees at the HKD/INR rate on the day you bought and the day you sold, so the currency move is part of the gain. Paasa's capital-gains statement gives you the figures for your return.